Insider Trading by Corporate Officers

This is a Texas news story, published by Yahoo Finance, that relates primarily to Terns Pharmaceuticals news.

Texas news

For more Texas news, you can click here:

more Texas news

stocks trading & speculation news

For more stocks trading & speculation news, you can click here:

more stocks trading & speculation news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about

insider trading

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest recent insider trades news, company insiders news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

insider trades

TipRanks

•

Here’s a look at two stocks that have recently seen multi-million dollar insider purchases

Summary

Nutrition label

70% Informative

Terns Pharmaceuticals is a biopharmaceutical research firm working at both the early development and the clinical trials stages.

The company has a clinical program underway in each of these areas, targeting chronic myeloid leukemia ( CML ) in the first and obesity, a major health issue, in the second .

Permian Resources is an independent oil and gas exploration and production firm operating in the rich oil fields of Texas .

The shares are currently trading at $ 9.73 , and the average target price, $ 19.80 , implies a 103% upside in the next 12 months .

The company announced on September 3 a large increase to its regular base dividend.

VR Score

Informative language

Neutral language

Article tone

semi-formal

Language

English

Language complexity

Offensive language